Location History:
- Castelnuovo Berardenga (SI), IT (2004)
- Vagliagli, IT (2000 - 2008)
- Castelnuovo Berardenga, IT (2004 - 2008)
- Siena, IT (2003 - 2010)
Company Filing History:
4 out of 245 
3 out of 656 
3 out of 19 
Years Active: 2000-2010
Title: The Innovations of Sergio Abrignani: Pioneering Research in Hepatitis C
Introduction
Sergio Abrignani, an accomplished inventor based in Siena, Italy, has made significant contributions to the field of immunology and virology. With a robust portfolio of 12 patents, Abrignani has focused his research on critical methods for understanding and diagnosing hepatitis C virus (HCV) and advancing immunization strategies.
Latest Patents
Two of Abrignani's latest patents illustrate the forefront of his work. The first, titled "Preparation of purified exosomes comprising HCV RNA," outlines a groundbreaking method for isolating hepatitis C virus. This innovative technique involves separating exosomes from the blood plasma of infected individuals and extracting RNA from these particles, providing new avenues for research and potential therapies. The second patent involves the identification of cytotoxic T-cell epitopes from proteins. This research has highlighted the inadequacies of algorithmic predictions in determining these epitopes and reveals their significance in immunization and diagnosis efforts.
Career Highlights
Throughout his career, Sergio Abrignani has collaborated with notable companies in the biotechnology sector, including Novartis Vaccines & Diagnostics and Chiron Corporation. These affiliations have allowed him to engage in groundbreaking research that bridges laboratory innovations and real-world applications, enhancing vaccine development and disease management strategies.
Collaborations
Abrignani has worked alongside distinguished colleagues such as Michael Houghton and Mark J. Selby. This collaboration has fostered an environment of shared knowledge and innovation, contributing to advancements in understanding hepatitis C and enhancing immunological responses.
Conclusion
Sergio Abrignani's work exemplifies the spirit of innovation in the field of medical research. His inventions continue to advance understanding and treatment options for hepatitis C, showcasing the impact of dedicated researchers in health science. Through his patents and collaborations, Abrignani remains a pivotal figure in the ongoing efforts to combat viral diseases and improve global health outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.